{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T03:21:50Z","timestamp":1775100110786,"version":"3.50.1"},"reference-count":83,"publisher":"International Heart Journal (Japanese Heart Journal)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. Heart J."],"published-print":{"date-parts":[[2016]]},"DOI":"10.1536\/ihj.16-094","type":"journal-article","created":{"date-parts":[[2016,5,12]],"date-time":"2016-05-12T22:06:07Z","timestamp":1463090767000},"page":"271-277","source":"Crossref","is-referenced-by-count":60,"title":["Pathophysiology and Management of Cardiovascular Manifestations in Marfan and Loeys\u2013Dietz Syndromes"],"prefix":"10.1536","volume":"57","author":[{"given":"Norifumi","family":"Takeda","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, The University of Tokyo Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Yagi","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, The University of Tokyo Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hironori","family":"Hara","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, The University of Tokyo Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayuki","family":"Fujiwara","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, The University of Tokyo Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daishi","family":"Fujita","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, The University of Tokyo Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kan","family":"Nawata","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Surgery, The University of Tokyo Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryo","family":"Inuzuka","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, The University of Tokyo Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Taniguchi","sequence":"additional","affiliation":[{"name":"Department of Orthopedic Surgery, The University of Tokyo Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mutsuo","family":"Harada","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, The University of Tokyo Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haruhiro","family":"Toko","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, The University of Tokyo Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Akazawa","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, The University of Tokyo Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Issei","family":"Komuro","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, The University of Tokyo Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"437","reference":[{"key":"1","unstructured":"1. Marfan AB. Un cas de deformation congenitale des quatre membres, plus prononcee aux extremites, caracterisee par l\u2019allongement des os avec un certain degre d\u2019amincissement. Bull Mem Soc Med Hop Paris 1896; 13: 220-6."},{"key":"2","unstructured":"2. Baer RW, Taussig HB, Oppenheimer EH. Congenital aneurysmal dilatation of the aorta associated with arachnodactyly. Bull Johns Hopkins Hosp 1943; 72: 309-31."},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Etter LE, Glover LP. Arachnodactyly complicated by dislocated lens and death from rupture of dissecting aneurysm of aorta. JAMA 1943; 123: 88-9.","DOI":"10.1001\/jama.1943.82840370001006"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Dietz HC, Cutting GR, Pyeritz RE, <i>et al<\/i>. Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene. Nature 1991; 352: 337-9.","DOI":"10.1038\/352337a0"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. De Paepe A, Devereux RB, Dietz HC, Hennekam RC, Pyeritz RE. Revised diagnostic criteria for the marfan syndrome. Am J Med Genet 1996; 62: 417-26.","DOI":"10.1002\/(SICI)1096-8628(19960424)62:4<417::AID-AJMG15>3.0.CO;2-R"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Ogawa N, Imai Y, Takahashi Y, <i>et al<\/i>. Evaluating Japanese patients with the marfan syndrome using high-throughput microarray-based mutational analysis of fibrillin-1 gene. Am J Cardiol 2011; 108: 1801-7.","DOI":"10.1016\/j.amjcard.2011.07.053"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Mizuguchi T, Collod-Beroud G, Akiyama T, <i>et al<\/i>. Heterozygous TGFBR2 mutations in Marfan syndrome. Nat Genet 2004; 36: 855-60.","DOI":"10.1038\/ng1392"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Loeys BL, Chen J, Neptune ER, <i>et al<\/i>. A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2. Nat Genet 2005; 37: 275-81.","DOI":"10.1038\/ng1511"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Loeys BL, Schwarze U, Holm T, <i>et al<\/i>. Aneurysm syndromes caused by mutations in the TGF-beta receptor. N Engl J Med 2006; 355: 788-98.","DOI":"10.1056\/NEJMoa055695"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. MacCarrick G, Black JH 3rd, Bowdin S, <i>et al<\/i>. Loeys-Dietz syndrome: a primer for diagnosis and management. Genet Med 2014; 16: 576-87. (Review)","DOI":"10.1038\/gim.2014.11"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Fujita D, Takeda N, Imai Y, Inuzuka R, Komuro I, Hirata Y. Pathophysiology and Japanese clinical characteristics in Marfan syndrome. Pediatr Int 2014; 56: 484-91.","DOI":"10.1111\/ped.12423"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Boileau C, Guo DC, Hanna N, <i>et al<\/i>. TGFB2 mutations cause familial thoracic aortic aneurysms and dissections associated with mild systemic features of Marfan syndrome. Nat Genet 2012; 44: 916-21.","DOI":"10.1038\/ng.2348"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Lindsay ME, Schepers D, Bolar NA, <i>et al<\/i>. Loss-of-function mutations in TGFB2 cause a syndromic presentation of thoracic aortic aneurysm. Nat Genet 2012; 44: 922-7.","DOI":"10.1038\/ng.2349"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Bertoli-Avella AM, Gillis E, Morisaki H, <i>et al<\/i>. Mutations in a TGF-<i>\u03b2<\/i> ligand, TGFB3, cause syndromic aortic aneurysms and dissections. J Am Coll Cardiol 2015; 65: 1324-36.","DOI":"10.1016\/j.jacc.2015.01.040"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. van de Laar IM, Oldenburg RA, Pals G, <i>et al<\/i>. Mutations in SMAD3 cause a syndromic form of aortic aneurysms and dissections with early-onset osteoarthritis. Nat Genet 2011; 43: 121-6.","DOI":"10.1038\/ng.744"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Regalado ES, Guo DC, Villamizar C, <i>et al<\/i>. Exome sequencing identifies SMAD3 mutations as a cause of familial thoracic aortic aneurysm and dissection with intracranial and other arterial aneurysms. Circ Res 2011; 109: 680-6.","DOI":"10.1161\/CIRCRESAHA.111.248161"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Byers PH. Determination of the molecular basis of marfan syndrome: a growth industry. J Clin Invest 2004; 114: 161-3.","DOI":"10.1172\/JCI200422399"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Loeys BL, Dietz HC, Braverman AC, <i>et al<\/i>. The revised Ghent nosology for the Marfan syndrome. J Med Genet 2010; 47: 476-85.","DOI":"10.1136\/jmg.2009.072785"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Bunton TE, Biery NJ, Myers L, Gayraud B, Ramirez F, Dietz HC. Phenotypic alteration of vascular smooth muscle cells precedes elastolysis in a mouse model of marfan syndrome. Circ Res 2001; 88: 37-43.","DOI":"10.1161\/01.RES.88.1.37"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. He R, Guo DC, Sun W, <i>et al<\/i>. Characterization of the inflammatory cells in ascending thoracic aortic aneurysms in patients with Marfan syndrome, familial thoracic aortic aneurysms, and sporadic aneurysms. J Thorac Cardiovasc Surg 2008; 136: 922-9.","DOI":"10.1016\/j.jtcvs.2007.12.063"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Radonic T, de Witte P, Groenink M, <i>et al<\/i>. Inflammation aggravates disease severity in Marfan syndrome patients. PLoS One 2012; 7: e32963.","DOI":"10.1371\/journal.pone.0032963"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Isogai Z, Ono RN, Ushiro S, <i>et al<\/i>. Latent transforming growth factor beta-binding protein 1 interacts with fibrillin and is a microfibril-associated protein. J Biol Chem 2003; 278: 2750-7.","DOI":"10.1074\/jbc.M209256200"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Jensen SA, Robertson IB, Handford PA. Dissecting the fibrillin microfibril: structural insights into organization and function. Structure 2012; 20: 215-25. (Review)","DOI":"10.1016\/j.str.2011.12.008"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. ten Dijke P, Arthur HM. Extracellular control of TGFbeta signalling in vascular development and disease. Nat Rev Mol Cell Biol 2007; 8: 857-69. (Review)","DOI":"10.1038\/nrm2262"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Neptune ER, Frischmeyer PA, Arking DE, <i>et al<\/i>. Dysregulation of TGF-beta activation contributes to pathogenesis in Marfan syndrome. Nat Genet 2003; 33: 407-11.","DOI":"10.1038\/ng1116"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Matt P, Schoenhoff F, Habashi J, <i>et al<\/i>. Circulating transforming growth factor-beta in Marfan syndrome. Circulation 2009; 120: 526-32.","DOI":"10.1161\/CIRCULATIONAHA.108.841981"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Faivre L, Collod-Beroud G, Loeys BL, <i>et al<\/i>. Effect of mutation type and location on clinical outcome in 1,013 probands with Marfan syndrome or related phenotypes and FBN1 mutations: an international study. Am J Hum Genet 2007; 81: 454-66.","DOI":"10.1086\/520125"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Baudhuin LM, Kotzer KE, Lagerstedt SA. Increased frequency of FBN1 truncating and splicing variants in Marfan syndrome patients with aortic events. Genet Med 2015; 17: 177-87.","DOI":"10.1038\/gim.2014.91"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Pereira L, Andrikopoulos K, Tian J, <i>et al<\/i>. Targetting of the gene encoding fibrillin-1 recapitulates the vascular aspect of Marfan syndrome. Nat Genet 1997; 17: 218-22.","DOI":"10.1038\/ng1097-218"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Pereira L, Lee SY, Gayraud B, <i>et al<\/i>. Pathogenetic sequence for aneurysm revealed in mice underexpressing fibrillin-1. Proc Natl Acad Sci U S A 1999; 96: 3819-23.","DOI":"10.1073\/pnas.96.7.3819"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Ng CM, Cheng A, Myers LA, <i>et al<\/i>. TGF-beta-dependent pathogenesis of mitral valve prolapse in a mouse model of Marfan syndrome. J Clin Invest 2004; 114: 1586-92.","DOI":"10.1172\/JCI200422715"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Judge DP, Biery NJ, Keene DR, <i>et al<\/i>. Evidence for a critical contribution of haploinsufficiency in the complex pathogenesis of Marfan syndrome. J Clin Invest 2004; 114: 172-81.","DOI":"10.1172\/JCI200420641"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Habashi JP, Judge DP, Holm TM, <i>et al<\/i>. Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome. Science 2006; 312: 117-21.","DOI":"10.1126\/science.1124287"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Holm TM, Habashi JP, Doyle JJ, <i>et al<\/i>. Noncanonical TGF<i>\u03b2<\/i> signaling contributes to aortic aneurysm progression in Marfan syndrome mice. Science 2011; 332: 358-61.","DOI":"10.1126\/science.1192149"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Cook JR, Clayton NP, Carta L, <i>et al<\/i>. Dimorphic effects of transforming growth factor-<i>\u03b2<\/i> signaling during aortic aneurysm progression in mice suggest a combinatorial therapy for Marfan syndrome. Arterioscler Thromb Vasc Biol 2015; 35: 911-7.","DOI":"10.1161\/ATVBAHA.114.305150"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Li W, Li Q, Jiao Y, <i>et al<\/i>. Tgfbr2 disruption in postnatal smooth muscle impairs aortic wall homeostasis. J Clin Invest 2014; 124: 755-67.","DOI":"10.1172\/JCI69942"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Ju X, Ijaz T, Sun H, <i>et al<\/i>. IL-6 regulates extracellular matrix remodeling associated with aortic dilation in a fibrillin-1 hypomorphic mgR\/mgR mouse model of severe Marfan syndrome. J Am Heart Assoc 2014; 3: e000476.","DOI":"10.1161\/JAHA.113.000476"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Ihling C, Szombathy T, Nampoothiri K, <i>et al<\/i>. Cystic medial degeneration of the aorta is associated with p53 accumulation, Bax upregulation, apoptotic cell death, and cell proliferation. Heart 1999; 82: 286-93.","DOI":"10.1136\/hrt.82.3.286"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Chung AW, Yang HH, Radomski MW, van Breemen C. Long-term doxycycline is more effective than atenolol to prevent thoracic aortic aneurysm in marfan syndrome through the inhibition of matrix metalloproteinase-2 and -9. Circ Res 2008; 102: e73-85.","DOI":"10.1161\/CIRCRESAHA.108.174367"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Emrich FC, Okamura H, Dalal AR, <i>et al<\/i>. Enhanced caspase activity contributes to aortic wall remodeling and early aneurysm development in a murine model of Marfan syndrome. Arterioscler Thromb Vasc Biol 2015; 35: 146-54.","DOI":"10.1161\/ATVBAHA.114.304364"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Merk DR, Chin JT, Dake BA, <i>et al<\/i>. miR-29b participates in early aneurysm development in Marfan syndrome. Circ Res 2012; 110: 312-24.","DOI":"10.1161\/CIRCRESAHA.111.253740"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. Marshall LM, Carlson EJ, O\u2019Malley J, <i>et al<\/i>. Thoracic aortic aneurysm frequency and dissection are associated with fibrillin-1 fragment concentrations in circulation. Circ Res 2013; 113: 1159-68.","DOI":"10.1161\/CIRCRESAHA.113.301498"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43. Fiorillo C, Becatti M, Attanasio M, <i>et al<\/i>. Evidence for oxidative stress in plasma of patients with Marfan syndrome. Int J Cardiol 2010; 145: 544-6.","DOI":"10.1016\/j.ijcard.2010.04.077"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44. Habashi JP, Doyle JJ, Holm TM, <i>et al<\/i>. Angiotensin II type 2 receptor signaling attenuates aortic aneurysm in mice through ERK antagonism. Science 2011; 332: 361-5.","DOI":"10.1126\/science.1192152"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45. Wisler JW, Harris EM, Raisch M, <i>et al<\/i>. The role of <i>\u03b2<\/i>-arrestin2-dependent signaling in thoracic aortic aneurysm formation in a murine model of Marfan syndrome. Am J Physiol Heart Circ Physiol 2015; 309: H1516-27.","DOI":"10.1152\/ajpheart.00291.2015"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46. Sorrentino A, Thakur N, Grimsby S, <i>et al<\/i>. The type I TGF-beta receptor engages TRAF6 to activate TAK1 in a receptor kinase-independent manner. Nat Cell Biol 2008; 10: 1199-207.","DOI":"10.1038\/ncb1780"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47. Ito Y, Yeo JY, Chytil A, <i>et al<\/i>. Conditional inactivation of Tgfbr2 in cranial neural crest causes cleft palate and calvaria defects. Development 2003; 130: 5269-80.","DOI":"10.1242\/dev.00708"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48. Dudas M, Kim J, Li WY, <i>et al<\/i>. Epithelial and ectomesenchymal role of the type I TGF-beta receptor ALK5 during facial morphogenesis and palatal fusion. Dev Biol 2006; 296: 298-314.","DOI":"10.1016\/j.ydbio.2006.05.030"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49. Iwata J, Hacia JG, Suzuki A, Sanchez-Lara PA, Urata M, Chai Y. Modulation of noncanonical TGF-<i>\u03b2<\/i> signaling prevents cleft palate in Tgfbr2 mutant mice. J Clin Invest 2012; 122: 873-85.","DOI":"10.1172\/JCI61498"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50. Horbelt D, Guo G, Robinson PN, Knaus P. Quantitative analysis of TGFBR2 mutations in Marfan-syndrome-related disorders suggests a correlation between phenotypic severity and Smad signaling activity. J Cell Sci 2010; 123: 4340-50.","DOI":"10.1242\/jcs.074773"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51. Cardoso S, Robertson SP, Daniel PB. TGFBR1 mutations associated with Loeys-Dietz syndrome are inactivating. J Recept Signal Transduct Res 2012; 32: 150-5.","DOI":"10.3109\/10799893.2012.664553"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52. Akhurst RJ. The paradoxical TGF-<i>\u03b2<\/i> vasculopathies. Nat Genet 2012; 44: 838-9.","DOI":"10.1038\/ng.2366"},{"key":"53","doi-asserted-by":"crossref","unstructured":"53. Gallo EM, Loch DC, Habashi JP, <i>et al<\/i>. Angiotensin II-dependent TGF-<i>\u03b2<\/i> signaling contributes to Loeys-Dietz syndrome vascular pathogenesis. J Clin Invest 2014; 124: 448-60.","DOI":"10.1172\/JCI69666"},{"key":"54","unstructured":"54. Ferguson-Smith MA, Wallace DC, James ZH, Renwick JH. Multiple self-healing squamous epithelioma. Birth Defects Orig Artic Ser 1971; 7: 157-63."},{"key":"55","doi-asserted-by":"crossref","unstructured":"55. Goudie DR, D\u2019Alessandro M, Merriman B, <i>et al<\/i>. Multiple self-healing squamous epithelioma is caused by a disease-specific spectrum of mutations in TGFBR1. Nat Genet 2011; 43: 365-9.","DOI":"10.1038\/ng.780"},{"key":"56","doi-asserted-by":"crossref","unstructured":"56. Robertson SJ, Bashir SJ, Pichert G, Robson A, Whittaker S. Severe exacerbation of multiple self-healing squamous epithelioma (Ferguson-Smith disease) with radiotherapy, which was successfully treated with acitretin. Clin Exp Dermatol 2010; 35: e100-2.","DOI":"10.1111\/j.1365-2230.2009.03668.x"},{"key":"57","doi-asserted-by":"crossref","unstructured":"57. Meijboom LJ, Timmermans J, van Tintelen JP, <i>et al<\/i>. Evaluation of left ventricular dimensions and function in Marfan\u2019s syndrome without significant valvular regurgitation. Am J Cardiol 2005; 95: 795-7.","DOI":"10.1016\/j.amjcard.2004.11.042"},{"key":"58","doi-asserted-by":"crossref","unstructured":"58. De Backer JF, Devos D, Segers P, <i>et al<\/i>. Primary impairment of left ventricular function in Marfan syndrome. Int J Cardiol 2006; 112: 353-8.","DOI":"10.1016\/j.ijcard.2005.10.010"},{"key":"59","doi-asserted-by":"crossref","unstructured":"59. Kiotsekoglou A, Moggridge JC, Bijnens BH, <i>et al<\/i>. Biventricular and atrial diastolic function assessment using conventional echocardiography and tissue-Doppler imaging in adults with Marfan syndrome. Eur J Echocardiogra 2009; 10: 947-55.","DOI":"10.1093\/ejechocard\/jep110"},{"key":"60","doi-asserted-by":"crossref","unstructured":"60. Alpendurada F, Wong J, Kiotsekoglou A, <i>et al<\/i>. Evidence for Marfan cardiomyopathy. Eur J Heart Fail 2010; 12: 1085-91.","DOI":"10.1093\/eurjhf\/hfq127"},{"key":"61","doi-asserted-by":"crossref","unstructured":"61. Das BB, Taylor AL, Yetman AT. Left ventricular diastolic dysfunction in children and young adults with Marfan syndrome. Pediatr Cardiol 2006; 27: 256-8.","DOI":"10.1007\/s00246-005-1139-5"},{"key":"62","doi-asserted-by":"crossref","unstructured":"62. Kahveci G, Erkol A, Yilmaz F. Dilated cardiomyopathy in a patient with Marfan syndrome accompanied by chronic type A aortic dissection and right atrial thrombus. Intern Med 2010; 49: 2583-6.","DOI":"10.2169\/internalmedicine.49.3880"},{"key":"63","doi-asserted-by":"crossref","unstructured":"63. Knosalla C, Weng YG, Hammerschmidt R, <i>et al<\/i>. Orthotopic heart transplantation in patients with Marfan syndrome. Ann Thorac Surg 2007; 83: 1691-5.","DOI":"10.1016\/j.athoracsur.2007.01.018"},{"key":"64","doi-asserted-by":"crossref","unstructured":"64. Audenaert T, De Pauw M, Fran\u00e7ois K, De Backer J. Type B aortic dissection triggered by heart transplantation in a patient with Marfan syndrome. BMJ Case Rep 2015; 2015.","DOI":"10.1136\/bcr-2015-211138"},{"key":"65","doi-asserted-by":"crossref","unstructured":"65. Nollen GJ, Meijboom LJ, Groenink M, <i>et al<\/i>. Comparison of aortic elasticity in patients with the marfan syndrome with and without aortic root replacement. Am J Cardiol 2003; 91: 637-40.","DOI":"10.1016\/S0002-9149(02)03330-1"},{"key":"66","doi-asserted-by":"crossref","unstructured":"66. Cook JR, Carta L, B\u00e9nard L, <i>et al<\/i>. Abnormal muscle mechanosignaling triggers cardiomyopathy in mice with Marfan syndrome. J Clin Invest 2014; 124: 1329-39.","DOI":"10.1172\/JCI71059"},{"key":"67","doi-asserted-by":"crossref","unstructured":"67. Rakesh K, Yoo B, Kim IM, Salazar N, Kim KS, Rockman HA. Beta-Arrestin-biased agonism of the angiotensin receptor induced by mechanical stress. Sci Signal 2010; 3: ra46.","DOI":"10.1126\/scisignal.2000769"},{"key":"68","doi-asserted-by":"crossref","unstructured":"68. Groenink M, den Hartog AW, Franken R, <i>et al<\/i>. Losartan reduces aortic dilatation rate in adults with Marfan syndrome: a randomized controlled trial. Eur Heart J 2013; 34: 3491-500.","DOI":"10.1093\/eurheartj\/eht334"},{"key":"69","doi-asserted-by":"crossref","unstructured":"69. Lacro RV, Dietz HC, Sleeper LA, <i>et al<\/i>. Atenolol versus losartan in children and young adults with Marfan\u2019s syndrome. N Engl J Med 2014; 371: 2061-71.","DOI":"10.1056\/NEJMoa1404731"},{"key":"70","doi-asserted-by":"crossref","unstructured":"70. Forteza A, Evangelista A, S\u00e1nchez V, <i>et al<\/i>. Efficacy of losartan vs. Atenolol for the prevention of aortic dilation in Marfan syndrome: a randomized clinical trial. Eur Heart J 2015 (in press)","DOI":"10.1093\/eurheartj\/ehv575"},{"key":"71","doi-asserted-by":"crossref","unstructured":"71. Doyle JJ, Doyle AJ, Wilson NK, <i>et al<\/i>. A deleterious gene-by-environment interaction imposed by calcium channel blockers in Marfan syndrome. Elife 2015; 4.","DOI":"10.7554\/eLife.08648"},{"key":"72","doi-asserted-by":"crossref","unstructured":"72. McLoughlin D, McGuinness J, Byrne J, <i>et al<\/i>. Pravastatin reduces Marfan aortic dilation. Circulation 2011; 124: S168-73.","DOI":"10.1161\/CIRCULATIONAHA.110.012187"},{"key":"73","doi-asserted-by":"crossref","unstructured":"73. David TE, David CM, Manlhiot C, Colman J, Crean AM, Bradley T. Outcomes of aortic valve-sparing operations in Marfan syndrome. J Am Coll Cardiol 2015; 66: 1445-53.","DOI":"10.1016\/j.jacc.2015.07.041"},{"key":"74","doi-asserted-by":"crossref","unstructured":"74. Goland S, Elkayam U. Cardiovascular problems in pregnant women with marfan syndrome. Circulation 2009; 119: 619-23.","DOI":"10.1161\/CIRCULATIONAHA.104.493569"},{"key":"75","doi-asserted-by":"crossref","unstructured":"75. Houston L, Tuuli M, Macones G. Marfan syndrome and aortic dissection in pregnancy. Obstet Gynecol 2011; 117: 956-60.","DOI":"10.1097\/AOG.0b013e3182107310"},{"key":"76","doi-asserted-by":"crossref","unstructured":"76. Task Force on the Management of Cardiovascular Diseases During Pregnancy of the European Society of Cadiology. Expert consensus document on management of cardiovascular diseases during pregnancy. Eur Heart J 2003; 24: 761-81.","DOI":"10.1016\/S0195-668X(03)00098-8"},{"key":"77","unstructured":"77. Manalo-Estrella P, Barker AE. Histopathologic findings in human aortic media associated with pregnancy. Arch Pathol 1967; 83: 336-41."},{"key":"78","doi-asserted-by":"crossref","unstructured":"78. Fujita D, Takeda N, Morita H, <i>et al<\/i>. A novel mutation of TGFBR2 causing Loeys-Dietz syndrome complicated with pregnancy-related fatal cervical arterial dissections. Int J Car-diol 2015; 201: 288-90.","DOI":"10.1016\/j.ijcard.2015.07.109"},{"key":"79","doi-asserted-by":"crossref","unstructured":"79. Tran-Fadulu V, Pannu H, Kim DH, <i>et al<\/i>. Analysis of multigenerational families with thoracic aortic aneurysms and dissections due to TGFBR1 or TGFBR2 mutations. J Med Genet 2009; 46: 607-13.","DOI":"10.1136\/jmg.2008.062844"},{"key":"80","doi-asserted-by":"crossref","unstructured":"80. Murdoch JL, Walker BA, Halpern BL, Kuzma JW, McKusick VA. Life expectancy and causes of death in the Marfan syndrome. N Engl J Med 1972; 286: 804-8.","DOI":"10.1056\/NEJM197204132861502"},{"key":"81","doi-asserted-by":"crossref","unstructured":"81. Yetman AT, Bornemeier RA, McCrindle BW. Long-term outcome in patients with marfan syndrome: is aortic dissection the only cause of sudden death? J Am Coll Cardiol 2003; 41: 329-32.","DOI":"10.1016\/S0735-1097(02)02699-2"},{"key":"82","doi-asserted-by":"crossref","unstructured":"82. Van der Donckt C, Van Herck JL, Schrijvers DM, <i>et al<\/i>. Elastin fragmentation in atherosclerotic mice leads to intraplaque neovascularization, plaque rupture, myocardial infarction, stroke, and sudden death. Eur Heart J 2015; 36: 1049-58.","DOI":"10.1093\/eurheartj\/ehu041"},{"key":"83","doi-asserted-by":"crossref","unstructured":"83. Sponseller PD, Hobbs W, Riley LH 3rd, Pyeritz RE. The thoracolumbar spine in Marfan syndrome. J Bone Joint Surg Am 1995; 77: 867-76.","DOI":"10.2106\/00004623-199506000-00007"}],"container-title":["International Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/57\/3\/57_16-094\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,7]],"date-time":"2019-09-07T16:02:07Z","timestamp":1567872127000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/57\/3\/57_16-094\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":83,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1536\/ihj.16-094","relation":{},"ISSN":["1349-2365","1349-3299"],"issn-type":[{"value":"1349-2365","type":"print"},{"value":"1349-3299","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]}}}